References
- M. F. Pittenger, D. E. Discher, B. M. Péault, D. G. Phinney, J. M. Hare and A. I. Caplan, Mesenchymal stem cell perspective: Cell biology to clinical progress, npj Regen. Med. 4(1) (2019) Article ID 22 (15 pages); https://doi.org/10.1038/s41536-019-0083-6
- P. Wanyan, X. Wang, N. Li, Y. Huang, Y. She and L. Zhang, Mesenchymal stem cells therapy for acute kidney injury: A systematic review with meta-analysis based on rat model, Front. Pharmacol. 14 (2023) Article ID 1099056 (14 pages); https://doi.org/10.3389/fphar.2023.1099056
- X. Han, J. Wang, R. Li, M. Huang, G. Yue, L. Guan, Y. Deng, W. Cai and J. Xu, Placental mesenchymal stem cells alleviate podocyte injury in diabetic kidney disease by modulating mitophagy via the SIRT1-PGC-1alpha-TFAM pathway, Int. J. Molecular Sci. 24(5) (2023) Article ID 22 (19 pages); https://doi.org/10.3390/ijms24054696
- S. Afra and M. M. Matin, Potential of mesenchymal stem cells for bioengineered blood vessels in comparison with other eligible cell sources, Cell Tissue Res. 380 (2020) 1–13; https://doi.org/10.1007/s00441-019-03161-0
- Z. W. Htay, C. F. S. Ng, Y. Kim, Y.-H. Lim, M. Iwagami and M. Hashizume, Associations between short-term exposure to ambient temperature and renal disease mortality in Japan during 1979–2019: A time-stratified case-crossover analysis, Environmental Epidemiol. 8(1) (2024) e293 (7 pages); https://doi.org/10.1097/ee9.0000000000000293
- K. Iseri, M. Iyoda, H. Ohtaki, K. Matsumoto, Y. Wada, T. Suzuki, Y. Yamamoto, T. Saito, K. Hihara, S. Tachibana, K. Honda and T. Shibata, Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats, Am. J. Physiol. Renal Physiol. 310(11) (2016) F1182-91; https://doi.org/10.1152/ajprenal.00165.2016
- R. J. Cheng, A. J. Xiong, Y. H. Li, S. Y. Pan, Q. P. Zhang, Y. Zhao, Y. Liu and T. N. Marion, Mesenchymal stem cells: Allogeneic MSC may be immunosuppressive but autologous MSC are dysfunctional in lupus patients, Front. Cell Dev. Biol. 7 (2019) Article ID 285 (13 pages); https://doi.org/10.3389/fcell.2019.00285
- J. Barbado, S. Tabera, A. Sánchez and J. García-Sancho, Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis, Lupus 27(13) (2018) 2161–2165; https://doi.org/10.1177/0961203318804922
- H. S. Kim, J. S. Lee, H. K. Lee, E. J. Park, H. W. Jeon, Y. J. Kang, T. Y. Lee, K. S. Kim, S. C. Bae, J. H. Park and S. B. Han, Mesenchymal stem cells ameliorate renal inflammation in adriamycin-induced nephropathy, Immune Netw. 19(5) (2019) e36 (10 pages); https://doi.org/10.4110/in.2019.19.e36
- N. Starc, M. Li, M. Algeri, A. Conforti, L. Tomao, A. Pitisci, F. Emma, G. Montini, P. Messa, F. Locatelli, M. E. Bernardo and M. Vivarelli, Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome, Cytotherapy 20(3) (2018) 322–334; https://doi.org/10.1016/j.jcyt.2017.12.001
- H. H. Chang, S. P. Hsu and C. T. Chien, Intrarenal transplantation of hypoxic preconditioned mesenchymal stem cells improves glomerulonephritis through anti-oxidation, anti-ER stress, anti-inflammation, anti-apoptosis, and anti-autophagy, Antioxidants (Basel) 9(1) (2019); Article ID 2 (17 pages) https://doi.org/10.3390/antiox9010002
- V. A. Varela, E. B. Oliveira-Sales, E. Maquigussa, F. T. Borges, P. P. Gattai, A. D. S. Novaes, C. G. Shimoura, R. R. Campos and M. A. Boim, Treatment with mesenchymal stem cells improves reno-vascular hypertension and preserves the ability of the contralateral kidney to excrete sodium, Kidney Blood Pressure Res. 44(6) (2019) 1404–1415; https://doi.org/10.1159/000503346
- M. Gregorini, R. Maccario, M.A. Avanzini, V. Corradetti, A. Moretta, C. Libetta, P. Esposito, F. Bosio, A. Dal Canton and T. Rampino, Antineutrophil cytoplasmic antibody-associated renal vasculitis treated with autologous mesenchymal stromal cells: evaluation of the contribution of immune-mediated mechanisms, Mayo Clinic Proc. 88(10) (2013) 1174–1179; https://doi.org/10.1016/j.mayocp.2013.06.021
- Y. Shi, J. Xie, M. Yang, J. Ma and H. Ren, Transplantation of umbilical cord mesenchymal stem cells into mice with focal segmental glomerulosclerosis delayed disease manifestation, Ann. Transl. Med. 7(16) (2019) Article ID 3 (9 pages); https://doi.org/10.21037/atm.2019.07.71
- F. Yu, J. Chen, X. Wang, Q. Cai, K. Chen and Y. He, MSC-Derived exosomes prevent peritoneal fibroblast transdifferentiation in peritoneal dialysis-associated peritoneal fibrosis, Nephrol. Dialysis Transplant. 38(Supplement_1) (2023) Article ID 4662 (1 page); https://doi.org/10.1093/ndt/gfad063c_4662
- E. Maličev and K. Jazbec, An overview of mesenchymal stem cell heterogeneity and concentration, Pharmaceuticals 17(3) (2024) Article ID 350 (14 pages); https://doi.org/10.3390/ph17030350
- S. Joshi, S. Allabun, S. Ojo, M. S. Alqahtani, P. K. Shukla, M. Abbas, C. Wechtaisong and H. M. Almohiy, Enhanced drug delivery system using mesenchymal stem cells and membrane-coated nanoparticles, Molecules 28(5) (2023) Article ID 2130 (25 pages); https://doi.org/10.3390/molecules28052130
- C. Qi, H. Shi, M. Fan, W. Chen, H. Yao, C. Jiang, L. Meng, S. Pang and R. Lin, Microvesicles from bone marrow-derived mesenchymal stem cells promote Helicobacter pylori-associated gastric cancer progression by transferring thrombospondin-2, Cell Commun. Signal. 21(1) (2023) Article ID 274 (15 pages); https://doi.org/10.1186/s12964-023-01127-y
- A. F. Wise, T. M. Williams, M. B. Kiewiet, N. L. Payne, C. Siatskas, C. S. Samuel and S. D. Ricardo, Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury, Am. J. Physiol. Renal Physiol. 306(10) (2014) F1222-35; https://doi.org/10.1152/ajprenal.00675.2013
- S. Qi and D. Wu, Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis, Int. J. Mol. Med. 32(6) (2013) 1262–1272; https://doi.org/10.3892/ijmm.2013.1517
- M. Han, Z. Zhang, Z. Liu, Y. Liu, H. Zhao, B. Wang, C. Zhang, H. Shang, Y. Li and S. Wang, Three-dimensional-cultured MSC-derived exosome with hydrogel for cerebral ischemia repair, Biomaterials Advan. 149 (2023) Article ID 213396; https://doi.org/10.1016/j.bioadv.2023.213396
- C. K. Ward, R. G. Gill, R. S. Liddell and J. E. Davies, Umbilical cord stem cell lysate: a new biologic injectate for the putative treatment of acute temporomandibular joint inflammation, J. Inflamm. Res. 16 (2023) 4287–4300; https://doi.org/10.2147/R.S420741
- S. J. Lee, M. O. Ryu, M. S. Seo, S. B. Park, J. O. Ahn, S. M. Han, K. S. Kang, D. H. Bhang and H. Y. Youn, Mesenchymal stem cells contribute to improvement of renal function in a canine kidney injury model, In vivo 31(6) (2017) 1115–1124; https://doi.org/10.21873/invivo.11177
- J. M. Quimby, T. L. Webb, D. S. Gibbons and S. W. Dow, Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: A pilot study, J. Feline Med. Surgery 13(6) (2011) 418–426; https://doi.org/10.1016/j.jfms.2011.01.005
- M. Taninokuchi Tomassoni, Y. Zhou, L. Braccischi, F. Modestino, J. Fukuda and C. Mosconi, Trans-arterial stem cell injection (TASI): The role of interventional radiology in regenerative medi cine, J. Clin. Med. 13(3) (2024) Article ID 910 (13 pages); https://doi.org/10.3390/jcm13030910
- S. Levitte, A. Ganguly, S. Frolik, A. A. Guevara-Tique, S. Patel, A. Tadas, O. Klein, D. Shyr, R. Agarwal-Hashmi and L. Beach, Precision delivery of steroids as a rescue therapy for gastrointestinal graft-versus-host disease in pediatric stem cell transplant recipients, J. Clin. Med. 12(13) (2023) Article ID 4229 (6 pages); https://doi.org/10.3390/jcm12134229
- E. Cambria, J. Steiger, J. Günter, A. Bopp, P. Wolint, S. P. Hoerstrup and M. Y. Emmert, Cardiac regenerative medicine: The potential of a new generation of stem cells, Transfusion Med. Hemo-therapy 43(4) (2016) 275–281; https://doi.org/10.1159/000448179
- Y.-H. Chen, T. Xiao, X.-M. Zheng, Y. Xu, K.-T. Zhuang, W.-J. Wang, X.-M. Chen, Q. Hong and G.-Y. Cai, Local renal treatments for acute kidney injury: A review of current progress and future translational opportunities, J. Endourology 38(5) (2024) 466–479; https://doi.org/10.1089/end.2023.0705
- R. Binato, T. de Souza Fernandez, C. Lazzarotto-Silva, B. Du Rocher, A. Mencalha, L. Pizzatti, L. F. Bouzas and E. Abdelhay, Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy, Cell Prolif. 46(1) (2013) 10–22; https://doi.org/10.1111/cpr.12002
- G. Cai, Y. Lu, J. Chen, D. Yang, R. Yan, M. Ren, S. He, S. Wu and Y. Zhao, Brain-wide mapping of c-Fos expression with fluorescence micro-optical sectioning tomography in a chronic sleep deprivation mouse model, Neurobiol. Stress 20 (2022) Article ID 100478 (13 pages); https://doi.org/10.1016/j.ynstr.2022.100478
- A. Mii, A. Shimizu, H. Yamaguchi and S. Tsuruoka, Renal complications after hematopoietic stem cell transplantation: Role of graft-versus-host disease in renal thrombotic microangiopathy, J. Nippon Med. School 87(1) (2020) 7–12; https://doi.org/10.1272/jnms.JNMS.2020_87-102
- H. Zhou, Z. Liu, Y. Wang, X. Wen, E. H. Amador, L. Yuan, X. Ran, L. Xiong, Y. Ran, W. Chen and Y. Wen, Colorectal liver metastasis: molecular mechanism and interventional therapy, Sig. Trans-duct. Target. Ther. 7(1) (2022) Article ID 70 (25 pages); https://doi.org/10.1038/s41392-022-00922-2
- D. Luger, M. J. Lipinski, P. C. Westman, D. K. Glover, J. Dimastromatteo, J. C. Frias, M. T. Albelda, S. Sikora, A. Kharazi and G. Vertelov, Intravenously delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy, Circulation Res. 120(10) (2017) 1598–1613; https://doi.org/10.1161/CIRCRESAHA.117.310599
- Y. Wang and Y. Guo, RenalGuard system and conventional hydration for preventing contrast- associated acute kidney injury in patients undergoing cardiac interventional procedures: A systematic review and meta-analysis, Int. J. Cardiology 333 (2021) 83–89; https://doi.org/10.1016/j.ij-card.2021.02.071
- R. H. Lee, A. A. Pulin, M. J. Seo, D. J. Kota, J. Ylostalo, B. L. Larson, L. Semprun-Prieto, P. Delafontaine and D. J. Prockop, Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6, Cell Stem Cell 5(1) (2009) 54–63; https://doi.org/10.1016/j.stem.2009.05.003
- S. Zonta, M. De Martino, G. Bedino, G. Piotti, T. Rampino, M. Gregorini, F. Frassoni, A. Dal Canton, P. Dionigi and M. Alessiani, Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: Endovenous or arterial?, Transplant. Proc. 42(4) (2010) 1336–1340; https://doi.org/10.1016/j.transproceed.2010.03.081
- T. Freyman, G. Polin, H. Osman, J. Crary, M. Lu, L. Cheng, M. Palasis and R. L. Wilensky, A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction, Eur. Heart J. 27(9) (2006) 1114–1122; https://doi.org/10.1093/eurheartj/ehi818
- D. Lu, Y. Li, L. Wang, J. Chen, A. Mahmood and M. Chopp, Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury, J. Neurotrauma 18(8) (2001) 813–819; https://doi.org/10.1089/089771501316919175
- P. Walczak, J. Zhang, A. A. Gilad, D. A. Kedziorek, J. Ruiz-Cabello, R. G. Young, M. F. Pittenger, P. C. van Zijl, J. Huang and J. W. Bulte, Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia, Stroke 39(5) (2008) 1569–1574; https://doi.org/10.1161/strokeaha.107.502047
- G. F. Muschler, C. Nakamoto and L. G. Griffith, Engineering principles of clinical cell-based tissue engineering, J. Bone Joint Surgery 86(7) (2004) 1541–1558; https://doi.org/10.2106/00004623-200407000-00029
- Y. K. Chang, M. H. Chen, Y. H. Chiang, Y. F. Chen, W. H. Ma, C. Y. Tseng, B. W. Soong, J. H. Ho and O. K. Lee, Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells, J. Biomed. Sci. 18 (2011) Article ID 54 (9 pages); https://doi.org/10.1186/1423-0127-18-54
- I. M. Barbash, P. Chouraqui, J. Baron, M. S. Feinberg, S. Etzion, A. Tessone, L. Miller, E. Guetta, D. Zipori, L. H. Kedes, R. A. Kloner and J. Leor, Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution, Circulation 108(7) (2003) 863–868; https://doi.org/10.1161/01.Cir.0000084828.50310.6a
- S. M. Devine, A. M. Bartholomew, N. Mahmud, M. Nelson, S. Patil, W. Hardy, C. Sturgeon, T. Hewett, T. Chung, W. Stock, D. Sher, S. Weissman, K. Ferrer, J. Mosca, R. Deans, A. Moseley and R. Hoffman, Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion, Exp. Hematology 29(2) (2001) 244–255; https://doi.org/10.1016/s0301-472x(00)00635-4
- J. Gao, J. E. Dennis, R. F. Muzic, M. Lundberg and A. I. Caplan, The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion, Cells Tissues Organs 169(1) (2001) 12–20; https://doi.org/10.1159/000047856
- S. M. Devine, C. Cobbs, M. Jennings, A. Bartholomew and R. Hoffman, Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates, Blood 101(8) (2003) 2999–3001; https://doi.org/10.1182/blood-2002-06-1830
- J. W. Lee, X. Fang, N. Gupta, V. Serikov and M. A. Matthay, Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung, PNAS 106(38) (2009) 16357–16362; https://doi.org/10.1073/pnas.0907996106
- G. Moll, R. Jitschin, L. von Bahr, I. Rasmusson-Duprez, B. Sundberg, L. Lönnies, G. Elgue, K. Nilsson-Ekdahl, D. Mougiakakos, J. D. Lambris, O. Ringdén, K. Le Blanc and B. Nilsson, Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses, PloS one 6(7) (2011) e21703 (9 pages); https://doi.org/10.1371/journal.pone.0021703
- I. U. Schraufstatter, R. G. Discipio, M. Zhao and S. K. Khaldoyanidi, C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation, J. Immunol. 182(6) (2009) 3827–3836; https://doi.org/10.4049/jimmunol.0803055
- A. I. Caplan and D. Correa, The MSC: an injury drugstore, Cell Stem Cell 9(1) (2011) 11–15; https://doi.org/10.1016/j.stem.2011.06.008
- A. Shabbir, D. Zisa, H. Lin, M. Mastri, G. Roloff, G. Suzuki and T. Lee, Activation of host tissue trophic factors through JAK-STAT3 signaling: A mechanism of mesenchymal stem cell-mediated cardiac repair, Am. J. Physiol. Heart Circul. Physiol. 299(5) (2010) H1428–1438; https://doi.org/10.1152/ajpheart.00488.2010